SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-203869
Filing Date
2023-08-04
Accepted
2023-08-04 16:10:54
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d513246ds3.htm S-3 314957
2 EX-4.5 d513246dex45.htm EX-4.5 307056
3 EX-4.8 d513246dex48.htm EX-4.8 98441
4 EX-4.9 d513246dex49.htm EX-4.9 103447
5 EX-4.10 d513246dex410.htm EX-4.10 83528
6 EX-5.1 d513246dex51.htm EX-5.1 25985
7 EX-23.1 d513246dex231.htm EX-23.1 1406
8 EX-FILING FEES d513246dexfilingfees.htm EX-FILING FEES 44577
9 GRAPHIC g513246dsp156.jpg GRAPHIC 3862
10 GRAPHIC g513246g04h00.jpg GRAPHIC 40943
  Complete submission text file 0001193125-23-203869.txt   1042376
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273712 | Film No.: 231144122
SIC: 2834 Pharmaceutical Preparations